Oncology

According to a news report in Nature, scientists at Sichuan University’s West China Hospital are on track to initiate a clinical trial that will administer CRISPR-Cas9—edited immune cells in patients diagnosed with lung cancer.

A letter published in The New England Journal of Medicine provides narrative of a clinical interference that has been documented with the much hailed multiple myeloma drug daratumumab.

A proof-of-concept study in ovarian cancer shows advantage of using liquid biopsy for the earlier detection of disease relapse.

While most adolescent survivors of childhood cancer have a good grip on their emotional well being, some frequently present with a combination of behavioral, emotional, and social symptoms, a new study published in the Journal of Clinical Oncology has concluded

On an earnings call yesterday, Novartis announced that the FDA has sent a complete response letter for their product pegfilgrastim, biosimilar to Neulesta.

During a health policy session at the annual meeting of the American Society of Clinical Oncology, Steven J. Katz, MD, MPH, discussed the Oncotype DX Breast Cancer Assay, and it's impact on recommendations for chemotherapy in early-stage breast cancer.

A study presented at the annual meeting of the American Society of Clinical Oncology by a group from Israel that evaluated the price trend of 30 anticancer agents following their launch, found that prices may increase by as much as 44% even after adjusting for inflation.

A long-term follow up study among Dutch women who underwent in-vitro fertilization (IVF) treatment in the Netherlands has failed to find an association between the treatment and an increased risk of breast cancer.

Research from The University of Texas MD Anderson Cancer Center has tried to fill the knowledge gaps that exist in the treatment of colorectal cancers that harbor mutations in genes involved in DNA mismatch repair.